BIALX
Price
$28.05
Change
-$0.11 (-0.39%)
Updated
Jul 13 closing price
Net Assets
2.21B
RNPCX
Price
$71.64
Change
-$0.96 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
Interact to see
Advertisement

BIALX vs RNPCX

BIALX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
BIALX vs. RNPCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIALX is a StrongBuy and RNPCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 170B vs. BIALX (2.21B). RNPCX pays higher dividends than BIALX: RNPCX (0.70) vs BIALX (0.33). BIALX was incepted earlier than RNPCX: BIALX (11 years) vs RNPCX (24 years). RNPCX (1.05) is less costly to investors than BIALX (0.91). RNPCX (23.00) and BIALX (22.00) have comparable annual turnover. BIALX has a lower initial minimum investment than RNPCX: BIALX (100) vs RNPCX (250). RNPCX annual gain was more profitable for investors over the last year : 6.93 vs. BIALX (-4.97). BIALX return over 5 years is better than : 24.09 vs. RNPCX (11.29).
BIALXRNPCXBIALX / RNPCX
Total Expense Ratio0.911.0587%
Annual Report Gross Expense Ratio0.911.0587%
Fund Existence11 years24 years-
Gain YTD-3.2305.152-63%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets2.21B170B1%
Annual Yield % from dividends0.330.7047%
Returns for 1 year-4.976.93-72%
Returns for 3 years27.2232.6583%
Returns for 5 years24.0911.29213%
Returns for 10 years188.35103.71182%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIEMX7.77N/A
N/A
Virtus SGA Emerging Markets Equity I
VESIX47.21N/A
N/A
Vanguard European Stock Instl
FSGAX48.69N/A
N/A
Franklin Small-Mid Cap Growth Adv
FBTDX177.71N/A
N/A
Franklin Biotechnology Discovery C
TSLTX6.45N/A
N/A
Transamerica Small Cap Value I3